ZyVersa Therapeutics, Inc. (ZVSA)
Develops experimental medicines for kidney and inflammatory diseases in clinical trials.
$0.12+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-37.3%
The outlook
ZVSA is trading near its 52-week lows at $0.116, well below both its 50- and 200-day moving averages. Analyst coverage appears thin on this micro-cap biotech stock. The current price sits only 10% of the way up from its annual low, reflecting significant downward pressure.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Market cap
$939,127
52-wk high
$0.30
52-wk low
$0.10
50-day avg
$0.16
200-day avg
$0.18
Trailing P/E
—